Why the study?
Frailty is associated with adverse outcomes in older ACS patients, but its impact on long-term clinical outcomes following invasive management of NSTEACS is unknown.
Does frailty increase the risk of long-term adverse clinical outcomes in older patients (≥75 years) undergoing invasive management for NSTEACS?
Does frailty increase the risk of long-term adverse clinical outcomes in older patients (≥75 years) undergoing invasive management for NSTEACS?
In older patients (≥75 years) undergoing invasive management for NSTEACS, frailty is significantly associated with a higher risk of long-term adverse cardiovascular and bleeding events at 5 years.
Answers are grounded in this paper and cite their sources.
Frailty may identify higher long-term risk after angiography in older NSTEACS patients; leaves open whether interventions modify outcomes.
Aim Frailty is associated with adverse outcomes in older patients with acute coronary syndrome (ACS). The impact of frailty on long-term clinical outcomes following invasive management of non-ST elevation ACS (NSTEACS) is unknown. Methods and results The multi-centre Improve Clinical Outcomes in high-risk patieNts with ACS 1 (ICON-1) prospective cohort study consisted of patients aged >75 years undergoing coronary angiography following NSTEACS. Patients were categorized by frailty assessed by Canadian Study of Health and Ageing Clinical Frailty Scale (CFS) and Fried criteria. The primary composite endpoint was all-cause mortality, unplanned revascularization, myocardial infarction, stroke, and bleeding. Of 263 patients, 33 (12.5%) were frail, 152 (57.8%) were pre-frail, and 78 (29.7%) were robust according to CFS. By Fried criteria, 70 patients (26.6%, mean age 82.1 years) were frail, 147 (55.9%, mean age 81.3 years) were pre-frail, and 46 (17.5%, mean age 79.9 years) were robust. The composite endpoint was more common at 5 years among patients with frailty according to CFS (frail: 22, 66.7%; pre-frail: 81, 53.3%; robust: 27, 34.6%, P = 0.003), with a similar trend when using Fried criteria (frail: 39, 55.7%; pre-frail: 72, 49.0%; robust: 16, 34.8%, P = 0.085). Frailty measured with both CFS and Fried criteria was associated with the primary endpoint [age and sex-adjusted hazard ratio (HR) compared with robust groups. CFS: 2.22, 95% confidence interval (CI) 1.23–4.02, P = 0.008; Fried: HR 1.81, 95% CI 1.00–3.27, P = 0.048]. Conclusion In older patients who underwent angiography following NSTEACS, frailty is associated with an increased risk of the primary composite endpoint at 5 years. Registration: Clinicaltrials.gov NCT01933581
No takes yet. Share an insight, caveat, or question.
Ratcovich et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: